These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 9841603)
1. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ohkusa T; Takashimizu I; Fujiki K; Suzuki S; Shimoi K; Horiuchi T; Sakurazawa T; Ariake K; Ishii K; Kumagai J; Tanizawa T Ann Intern Med; 1998 Nov; 129(9):712-5. PubMed ID: 9841603 [TBL] [Abstract][Full Text] [Related]
2. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. Ji F; Wang ZW; Ning JW; Wang QY; Chen JY; Li YM World J Gastroenterol; 2006 Mar; 12(11):1770-3. PubMed ID: 16586550 [TBL] [Abstract][Full Text] [Related]
3. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Ohkusa T; Miwa H; Hojo M; Kumagai J; Tanizawa T; Asaoka D; Terai T; Ohkura R; Sato N Digestion; 2003; 68(2-3):57-62. PubMed ID: 14581761 [TBL] [Abstract][Full Text] [Related]
4. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer? Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen. Adachi K; Ishihara S; Hashimoto T; Hirakawa K; Ishimura N; Niigaki M; Kaji T; Kawamura A; Sato H; Fujishiro H; Hattori S; Watanabe M; Kinoshita Y Aliment Pharmacol Ther; 2001 Aug; 15(8):1187-91. PubMed ID: 11472321 [TBL] [Abstract][Full Text] [Related]
7. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980 [TBL] [Abstract][Full Text] [Related]
8. High-dose ecabet sodium improves the eradication rate of helicobacter pylori in dual therapy with lansoprazole and amoxicillin. Kagaya H; Kato M; Komatsu Y; Mizushima T; Sukegawa M; Nishikawa K; Hokari K; Takeda H; Sugiyama T; Asaka M Aliment Pharmacol Ther; 2000 Nov; 14(11):1523-7. PubMed ID: 11069325 [TBL] [Abstract][Full Text] [Related]
9. Dose-dependent inhibition of CYP3A activity by clarithromycin during Helicobacter pylori eradication therapy assessed by changes in plasma lansoprazole levels and partial cortisol clearance to 6beta-hydroxycortisol. Ushiama H; Echizen H; Nachi S; Ohnishi A Clin Pharmacol Ther; 2002 Jul; 72(1):33-43. PubMed ID: 12152002 [TBL] [Abstract][Full Text] [Related]
10. Combination therapies with a proton pump inhibitor for Helicobacter pylori-infected gastric ulcer patients. Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Shimoyama T J Clin Gastroenterol; 1995; 20 Suppl 2():S132-5. PubMed ID: 7594330 [TBL] [Abstract][Full Text] [Related]
11. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185 [TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial. Nam SY; Lee SW; Jeon SW; Kwon YH; Lee HS Dig Dis Sci; 2020 Dec; 65(12):3652-3659. PubMed ID: 31974914 [TBL] [Abstract][Full Text] [Related]
13. Healing of cimetidine-resistant Ménétrier's disease by eradication of Helicobacter pylori infection. Shimoyama T; Fukuda S; Tanaka M; Mikami T; Yamagata R; Yoshimura T; Haga Y; Murata Y; Munakata A J Clin Gastroenterol; 1998 Dec; 27(4):348-50. PubMed ID: 9855268 [TBL] [Abstract][Full Text] [Related]
14. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S; J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773 [TBL] [Abstract][Full Text] [Related]
15. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer]. Kayser S; Flury R; Zbinden R; Fried M; Wirth HP Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483 [TBL] [Abstract][Full Text] [Related]
16. Disappearance of multiple hyperplastic polyps after the eradication of Helicobacter pylori. Suzuki S; Ohkusa T; Shimoi K; Horiuchi T; Fujiki K; Takashimizu I Gastrointest Endosc; 1997 Dec; 46(6):566-8. PubMed ID: 9434232 [No Abstract] [Full Text] [Related]
17. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [TBL] [Abstract][Full Text] [Related]
18. Maastricht II treatment scheme and efficacy of different proton pump inhibitors in eradicating Helicobacter pylori. Altintas E; Sezgin O; Ulu O; Aydin O; Camdeviren H World J Gastroenterol; 2004 Jun; 10(11):1656-8. PubMed ID: 15162544 [TBL] [Abstract][Full Text] [Related]
19. The effect of eradicating Helicobacter pylori infection on the course of adenomatous and hyperplastic gastric polyps. Ljubicić N; Banić M; Kujundzić M; Antić Z; Vrkljan M; Kovacević I; Hrabar D; Doko M; Zovak M; Mihatov S Eur J Gastroenterol Hepatol; 1999 Jul; 11(7):727-30. PubMed ID: 10445791 [TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Schwizer W; Thumshirn M; Dent J; Guldenschuh I; Menne D; Cathomas G; Fried M Lancet; 2001 Jun; 357(9270):1738-42. PubMed ID: 11403809 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]